Revolution Medicines, Inc 10-K for FY2022
Revolution Medicines, Inc. (RVMD)
10-K
2023-02-27
For: 2022-12-31
View Original
Added on
April 10, 2026
About this 10-K
Revolution Medicines, Inc filed this 10-K on February 27, 2023, covering the fiscal year ended December 31, 2022 (FY2022).
Headline figures
Fiscal year ended December 31, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $35.38M
- up 20.4% from $29.39M a year earlier
- Net loss
- $248.71M
- compared with a net loss of $187.09M a year earlier
- Diluted EPS
- -$3.08
- compared with -$2.57 a year earlier